Profusa, Inc. (NVACW) Warrants
Each NVACW warrant gives the holder the right to buy 1/7,500 share of Profusa, Inc. at $86,250 per share, until July 11, 2030. The stock last closed at $0.35, below the strike, so the warrant is out of the money. Profusa, Inc. has a market value of about $1.96M. There are 9.49M listed warrants; exercising all of them would add 0.0% to the 5.68M shares outstanding.
Profusa, Inc. reports its business to the SEC as “Surgical & Medical Instruments & Apparatus”, with its head office in New York, NY; it is incorporated in Delaware. The NVACW warrants were first issued by a SPAC and became Profusa, Inc. warrants when the merger closed on July 11, 2025. Its latest SEC filing was on November 13, 2026: quarterly report, form 10-Q. PFSA trades at 0.0004% of the strike; it would have to rise about 249,638-fold to reach it.
Why is the strike so large? Profusa, Inc. has combined its shares in one or more reverse splits. The strike is quoted per whole share, so it rose each time, and each warrant now buys only 1/7,500 of a share. Exercising one warrant costs $11.50.
Thinly traded: NVACW has not traded in the last 30 days. The last price may be out of date, and there may be no buyer or seller when you want one.
Key terms
- Strike per share
- $86,250
- Shares per warrant
- 1/7,500
- Cash to exercise one warrant
- $11.50
- Expiry
- 2030-07-11
- Redemption trigger
- none stated
- Cashless exercise
- allowed
- Break-even stock price
- $86,288
Checked against the issuer's SEC filing of 2026. The terms were first set out in its 8-K of 2021-12-23.
Exercise calculator
Each warrant buys 1/7,500 share at $86,250. Before expiry a warrant usually sells for more than its exercise value, because it still has time left. Fees and taxes are not included. Arithmetic, not investment advice.
Company and stock
- Company
- Profusa, Inc.
- Underlying stock
- PFSA
- Share price
- $0.35
- Market cap
- $1.96M
- Shares outstanding
- 5.68M
- 12-month range
- $0.35 – $371.25
- 12-month change
- -100%
- Value of all listed warrants
- $47.44K (2.4% of market cap)
- Industry
- Surgical & Medical Instruments & Apparatus
- Head office
- New York, NY
- Incorporated in
- Delaware
Market cap is the last share price times shares outstanding (as of 2026-11-13). Industry and head office are as the company reports them to the SEC. All SEC filings for this company.
Dilution
- Shares outstanding
- 5.68M
- Listed warrants
- 9.49M
- Dilution if all exercised
- 0.0%
Warrant count from the data the company files with the SEC.
Filings
- 10-QQuarterly report
- PRE 14ADraft proxy
- 8-KCurrent report: material agreement; new debt
- 8-KCurrent report: material agreement; new debt; unregistered sale of shares
- 8-KCurrent report: auditor changed
- 8-KCurrent report: material agreement; new debt
- 8-KCurrent report: shareholder vote results
- 8-KCurrent report: material agreement; new debt
- 8-KCurrent report: other events
- 8-KCurrent report: material agreement; new debt
The company's latest SEC filings, checked every night. Insider trades and routine SEC paperwork are left out. All SEC filings for this company.
Events
- Terms checked against an SEC filing
- Merger closed; the warrants became warrants of the combined company
Questions about NVACW
When does the NVACW warrant expire?
NVACW expires on July 11, 2030.
What is the strike price of NVACW?
$86,250 per share; each warrant converts into 1/7,500 share, so exercising one warrant costs $11.50.
Can Profusa, Inc. redeem the NVACW warrants early?
The source filing we read lists no stock-price redemption trigger.
How many NVACW warrants are outstanding?
9.49M listed warrants, equal to 0.0% dilution if all are exercised.
Related warrants
Get an email when alerts open
Follow NVACW with the button at the top to get its alerts. Alerts are coming soon; leave your email and we will tell you when they open.

